Elevated Financial Group’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$898K Sell
776
-210
-21% -$248K 0.25% 49
2026
Q2
$1.18M Sell
986
-2,516
-72% -$2.57M 0.32% 42
2026
Q1
$3.22M Buy
3,502
+2,322
+197% +$2.35M 1.05% 21
2025
Q4
$1.27M Buy
+1,180
New +$1.13M 0.44% 35

Other funds holding LLY

Elevated Financial Group's LLY Position: Q3 2026 in Review

Elevated Financial Group reduced its Eli Lilly (LLY) stake by 21% in Q3 2026, selling an estimated $248K and leaving 776 shares worth $898K. The position accounts for 0.25% of the portfolio, ranked #49.

Elevated Financial Group first reported a position in LLY in Q4 2025 and has held it in 4 quarters since. The position peaked at $3.22M in Q1 2026. 4,624 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • Elevated Financial Group held 776 shares of Eli Lilly worth $898K as of Q3 2026.
  • Elevated Financial Group sold 210 Eli Lilly shares in Q3 2026, an estimated $248K.
  • Eli Lilly made up 0.25% of Elevated Financial Group's portfolio in Q3 2026, its #49 holding.
  • Elevated Financial Group first reported a position in Eli Lilly in Q4 2025 and has held it in 4 quarters since.
  • Elevated Financial Group's Eli Lilly position peaked at $3.22M in Q1 2026.
  • 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Elevated Financial Group's 13F filing for Q3 2026, filed 16 Oct 2026.